Daratumumab (anti-CD38)
Product Specifications
CAS Number
945721-28-8
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882952-100 1x 100 µL
C1QA / Complement C1q A-Chain (C1QA/2952), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
bs-17894R-Cy5.5 100 µL
MtRNA polymerase Polyclonal Antibody, Cy5.5 Conjugated
Sign In for Pricing
View Details 